SALTARELLA, ILARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.828
EU - Europa 448
AS - Asia 310
SA - Sud America 21
OC - Oceania 1
Totale 2.608
Nazione #
US - Stati Uniti d'America 1.816
CN - Cina 150
SE - Svezia 138
SG - Singapore 115
IT - Italia 102
DE - Germania 36
RU - Federazione Russa 35
FI - Finlandia 34
GB - Regno Unito 31
BE - Belgio 25
VN - Vietnam 24
FR - Francia 20
BR - Brasile 16
CA - Canada 10
IN - India 8
PL - Polonia 6
IE - Irlanda 4
IR - Iran 4
CL - Cile 3
CZ - Repubblica Ceca 3
NO - Norvegia 3
HU - Ungheria 2
LT - Lituania 2
NL - Olanda 2
UA - Ucraina 2
AR - Argentina 1
AU - Australia 1
BY - Bielorussia 1
CY - Cipro 1
ID - Indonesia 1
IQ - Iraq 1
JM - Giamaica 1
JP - Giappone 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MX - Messico 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 2.608
Città #
Fairfield 229
Chandler 219
Ashburn 188
Woodbridge 147
Nyköping 129
Seattle 114
Cambridge 106
Ann Arbor 104
Wilmington 102
Houston 95
Singapore 81
New York 58
Bari 48
Beijing 44
Roxbury 31
Lawrence 30
Helsinki 27
Brussels 25
Nanjing 25
Dong Ket 23
Los Angeles 19
Brooklyn 18
Des Moines 17
San Diego 15
Dearborn 14
London 13
Washington 13
Inglewood 12
Munich 12
Marseille 10
Santa Clara 9
Jacksonville 8
Princeton 8
Guangzhou 7
Jiaxing 7
Paris 7
Toronto 7
Rome 6
Boardman 4
Dublin 4
Grafing 4
Pune 4
Radomsko 4
Barletta 3
Brno 3
Chicago 3
Frankfurt am Main 3
Grottaglie 3
Hebei 3
Jinan 3
Kunming 3
Nanchang 3
Redwood City 3
Shanghai 3
Suri 3
São Paulo 3
Augusta 2
Budapest 2
Changsha 2
Espoo 2
Lianyun 2
Milan 2
Münster 2
Nuremberg 2
Oslo 2
Putignano 2
Reggio Calabria 2
Santiago 2
Shenyang 2
Shenzhen 2
Tianjin 2
Acton 1
Almirante Tamandaré 1
Ardabil 1
Arealva 1
Ashgabat 1
Avellaneda 1
Baotou 1
Bitetto 1
Brasília 1
Bratislava 1
Caldas Novas 1
Chengdu 1
Chongqing 1
Cincinnati 1
Clifton 1
Erbil 1
Ergolding 1
Falkenstein 1
Florence 1
Fuzhou 1
Gurgaon 1
Hefei 1
Hengyang 1
Ho Chi Minh City 1
Indaiatuba 1
Independência 1
Islington 1
Istanbul 1
Jianning 1
Totale 2.145
Nome #
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients 136
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trial 136
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes 126
Involvement of NOTCH signaling in multiple myeloma angiogenesis and progression 118
Role of erythropoietin in the angiogenic activity of bone marrow endothelial cells of MGUS and multiple myeloma patients 117
Identify multiple myeloma stem cells: Utopia? 113
Survivin overexpression in head and neck squamous cell carcinomas as a new therapeutic target (Review) 113
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 111
Functional and biological role of endothelial precursor cells in tumour progression: A new potential therapeutic target in haematological malignancies 108
null 101
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma–Enhanced Angiogenesis: A Novel Therapeutic Target? 99
Autophagy: A New Mechanism of Prosurvival and Drug Resistance in Multiple Myeloma 88
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study 88
Different Adaptive Responses to Hypoxia in Normal and Multiple Myeloma Endothelial Cells 87
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma 87
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma 84
Bortezomib treatment modulates autophagy in multiple myeloma 77
“Exosomes-Mediate Crosstalk in Multiple Myeloma progression and drug Resistance” 72
Inhibition of endothelial and plasma cells NOTCH mediated comunication reduces angiogenesis in multiple myeloma patients. 69
Functional interplay between NIK and c-Abl kinases limits response to Aurora inhibitors in multiple myeloma. 61
Inhibition of Notch mediated communication in endothelial and plasma cells reduces angiogenesis in multiple myeloma patients. 58
Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? 57
Inhibition of Notch-mediated crosstalk between endothelial cells and plasmacells reduces angiogenesis in multiple myeloma patients. 52
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma 52
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma 50
Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma 44
MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease 41
Myeloma cells regulate {miRNA} transfer from fibroblast-derived exosomes by expression of {lncRNAs} 38
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer 37
Antiangiogenic drugs as chemosensitizers in hematological tumors 33
null 31
null 30
Chaperone activity of niflumic acid on ClC-1 chloride channel mutants causing myotonia congenita 28
The “angiogenic switch” from MGUS to MM: what about the Notch role? 28
Thrombopoietin promotes angiogenesis and disease progression in patients with multiple myeloma 27
Cardiovascular risk in patients with Takayasu arteritis directly correlates with diastolic dysfunction and inflammatory cell infiltration in the vessel wall: a clinical, ex vivo and in vitro analysis. 26
The Landscape of lncRNAs in Multiple Myeloma: Implications in the “Hallmarks of Cancer”, Clinical Perspectives and Therapeutic Opportunities 25
Immersive and Non-Immersive Virtual Reality for Pain and Anxiety Management in Pediatric Patients with Hematological or Solid Cancer: A Systematic Review 18
Anti-Angiogenic Activity of Drugs in Multiple Myeloma 18
CORRELATION BETWEEN VASCULAR INFLAMMATION MARKERS, DIASTOLIC DYSFUNCTION AND CARDIOVASCULAR RISK IN PATIENTS WITH TAKAYASU ARTERITIS 17
Improvement of daratumumab- or elotuzumab-mediated NK cell activity by the bi-specific 4-1BB agonist, DARPin α-FAPx4-1BB: A preclinical study in multiple myeloma 16
Notch cross-talk between endothelial cells and plasma cells in bone marrow of multiple myeloma patients 15
Ion Channels in Multiple Myeloma: Pathogenic Role and Therapeutic Perspectives 15
Coexistence of SCN4A and CLCN1 mutations in a family with atypical myotonic features: A clinical and functional study 14
Drug repurposing in skeletal muscle ion channelopathies 14
MicroRNAs-based nano-strategies as new therapeutic approach in multiple myeloma to overcome disease progression and drug resistance 14
ECM Composition Differentially Regulates Intracellular and Extracellular pH in Normal and Cancer Pancreatic Duct Epithelial Cells 13
Uptake-Dependent and -Independent Effects of Fibroblasts-Derived Extracellular Vesicles on Bone Marrow Endothelial Cells from Patients with Multiple Myeloma: Therapeutic and Clinical Implications 13
Development of Riluzole Analogs with Improved Use-Dependent Inhibition of Skeletal Muscle Sodium Channels 12
Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance 12
A c.1775C > T Point Mutation of Sodium Channel Alfa Subunit Gene (SCN4A) in a Three-Generation Sardinian Family with Sodium Channel Myotonia 11
Role of extracellular vesicle-based cell-to-cell communication in multiple myeloma progression 11
Immunoglobulin Replacement Therapy: Insights into Multiple Myeloma Management 8
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 5
Totale 2.874
Categoria #
all - tutte 14.610
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.610


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020371 0 0 0 0 0 48 56 68 62 62 49 26
2020/2021519 14 30 34 45 100 30 39 47 25 71 38 46
2021/2022282 20 21 3 11 9 18 18 16 23 22 40 81
2022/2023560 52 89 45 44 51 70 11 74 84 11 15 14
2023/2024305 15 34 18 23 48 114 8 7 5 7 8 18
2024/2025402 47 24 63 64 90 114 0 0 0 0 0 0
Totale 2.874